Ticker Details
Xencor, Inc. Xencor Inc is engaged in the field of biotechnology. The United States-based firm develops drugs to combat severe diseases such as allergies and cancers.
IPO Date:	December 3, 2013
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$918.93M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.55 | 2.33%
Avg Daily Range (30 D):	$0.35 | 2.93%
Avg Daily Range (90 D):	$0.36 | 2.67%

Institutional Daily Volume
Avg Daily Volume:	.28M
Avg Daily Volume (30 D):	.73M
Avg Daily Volume (90 D):	.55M

Trade Size
Avg Trade Size (Sh.):	68
Avg Trade Size (Sh.) (30 D):	64
Avg Trade Size (Sh.) (90 D):	60

Institutional Trades
Total Institutional Trades:	3,264
Avg Institutional Trade:	$1.99M
Avg Institutional Trade (30 D):	$1.95M
Avg Institutional Trade (90 D):	$2.04M
Avg Institutional Trade Volume:	.08M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.25M
Avg Closing Trade (30 D):	$2.15M
Avg Closing Trade (90 D):	$2.24M
Avg Closing Volume:	92.32K

News

Feb 18, 2026 @ 4:00 PM CTLA-4 Inhibitors Competitive Landscape Research R... Source: Researchandmarkets.Com

Jan 14, 2026 @ 8:30 AM [Latest] Global T-Cell Engagers Market Size/Share ... Source: Custom Market Insights

Aug 6, 2025 @ 8:13 PM Xencor (XNCR) Q2 Revenue Jumps 82% Source: Not Specified

Jul 16, 2025 @ 4:30 AM [Latest] Global Ultomiris Drug Market Size/Share W... Source: Custom Market Insights

Sep 12, 2024 @ 5:09 PM Xencor Surges 10.5%: Is This an Indication of Furt... Source: Zacks

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-1.24	$-.09	$-1.24
Diluted EPS	$-1.24	$-.09	$-1.24
Revenue	$125.58M	$28.24M	$125.58M
Gross Profit
Net Income / Loss	$-92.14M	$-6.65M	$-92.14M
Operating Income / Loss	$-177.5M	$-53.63M	$-177.5M
Cost of Revenue
Net Cash Flow	$13.1M	$25.78M	$13.1M
PE Ratio